While these conditions may all require a vitrectomy, they are very different conditions. The visual results can vary depending on the underlying condition and its severity. Your specialist will always discuss your treatment and its expected outcomes with you, so you have the best idea of what to expect after surgery.
Eye treatment options can be confusing. We’ve made the journey as straightforward as can be
Get in touch
The first step is to call us so we can answer any questions we can on the phone. Give our friendly team a call on 0800 99 2020 or request a call back from us.
At your consultation, we’ll diagnose your issues, answer your questions and give you a clear recommendation based on your needs. You’ll confidently leave with a clear understanding of your treatment options.
After treatment, people often tell us how pleased they were that they took action when they did. They’re often so glad that they reached out so that we could address their concerns and help them resolve their troublesome eye condition.
We are proud to be associated with top quality private medical insurers
Give us a call to understand how your insurance can help cover your treatment
Watch the best patient education videos on eye treatment in New Zealand
Get a quick overview of everything you need to know about gaining visual freedom
As part of his ophthalmology specialty training, Dr Dunne gained valuable experience in major centres such as Auckland and Wellington, with a final two years undertaking Medical Retina advanced training based at the Greenlane Eye Clinic in Auckland. LEARN MORE
Pars plana vitrectomy (PPV) is a commonly employed technique in vitreoretinal surgery that enables access to the posterior segment for treating conditions such as retinal detachments, vitreous hemorrhage, endophthalmitis, and macular holes in a controlled, closed system. The procedure derives its name from the fact that vitreous is removed (i.e. vitreous + ectomy = removal of vitreous) and the instruments are introduced into the eye through the pars plana. Click here to read more.